Evommune, Inc. (EVMN)
17.05
-0.07
(-0.41%)
USD |
NYSE |
Jan 02, 12:14
Evommune Total Assets (Quarterly): 84.54M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| BillionToOne, Inc. | 327.52M |
| PTC Therapeutics, Inc. | 2.644B |
| Spyre Therapeutics, Inc. | 504.60M |
| Denali Therapeutics, Inc. | 1.056B |
| Quince Therapeutics, Inc. | 109.90M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 267.68M |
| Shareholders Equity (Quarterly) | -183.14M |
| Debt to Equity Ratio | -1.408 |
| Current Ratio | 7.761 |